Related Experiment Videos

[Meningococcal W135 infection epidemics associated with pilgrimage to Mecca in 2000]

M D Matsika-Claquin1, A Perrocheau, M K Taha

  • 1Institut de Veille Sanitaire, 12, rue du Val d'Osne, F94415 Saint-Maurice.

Presse Medicale (Paris, France : 1983)
|November 28, 2001
PubMed
Abstract

Insights

Neisseria meningitidis serogroup W135 infections, rare in France, caused an outbreak among pilgrims. Preventive measures, including rifampicin chemotherapy, were implemented, and vaccination is recommended for future events.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Microbiology

Context:

  • An outbreak of Neisseria meningitidis serogroup W135 (NmW135) occurred in France following the 2000 Hajj pilgrimage.
  • This serogroup and clonal complex (ET37) were rarely seen in France but associated with epidemics elsewhere.
  • The outbreak presented a public health challenge due to its unusual nature and high mortality.

Purpose:

  • To investigate the NmW135 outbreak in France.
  • To describe the epidemic's characteristics and strain diffusion.
  • To assess the impact of implemented preventive measures and inform future strategies.

Summary:

  • The investigation identified 25 confirmed and 2 probable NmW135 cases between March and November 2000, with an 18% mortality rate.
  • Cases were observed among pilgrims, their close contacts, and even individuals with no identifiable link, suggesting sustained transmission.
  • Rifampicin chemoprophylaxis appeared effective, as no cases occurred among those who received it, though some cases arose after prophylaxis recommendations were issued.

Impact:

  • The study highlights the potential for rare meningococcal strains to emerge and spread.
  • It underscores the importance of rapid public health response, including chemotherapy and vaccination recommendations.
  • The findings support the use of quadrivalent (A, C, W135, Y) meningococcal vaccines for future pilgrimages to prevent similar outbreaks.

Related Concept Videos